Know Cancer

or
forgot password

LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma


Phase 2
N/A
21 Years
Not Enrolling
Both
Non-Hodgkin's Lymphoma

Thank you

Trial Information

LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma


Inclusion Criteria:



- Non-Hodgkin's Lymphoma stages III, IV, IVA with

1. T cell lymphomas, any primary site irrespective of LDH level

2. large cell lymphomas, any primary site irrespective of LDH level

3. B cell lymphomas, any primary site with initial LDH of less than 500

Exclusion Criteria:

- B cell lymphomas, any primary site with initial LDH of less than 500 and initial CNS
or bone involvement

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Non-Hodgkin Cancer does not return 3 years after completing treatment

Outcome Time Frame:

330 Days

Safety Issue:

Yes

Principal Investigator

Tanya Trippett, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

90-042

NCT ID:

NCT00610883

Start Date:

May 1990

Completion Date:

December 2008

Related Keywords:

  • Non-Hodgkin's Lymphoma
  • Lymphoma
  • Lymphoma, Non-Hodgkin

Name

Location

Memorial Sloan-Kettering Cancer Center New York, New York  10021